[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100589054":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":31,"centralContacts":37,"locations":48,"responsibleParty":67,"collaborators":70,"id":74,"slug":75,"hasResults":76,"nctId":77,"briefTitle":78,"officialTitle":79,"acronym":80,"eligibilityCriteria":81,"healthyVolunteers":76,"sex":82,"minAge":83,"maxAge":84,"enrollmentInfo":85,"targetDuration":26,"studyType":88,"phases":89,"briefSummary":91,"conditions":92,"keywords":95,"overallStatus":51,"whyStopped":26,"lastUpdateSubmitDate":100,"lastUpdatePostDateStruct":101,"startDateStruct":104,"completionDateStruct":106,"leadSponsor":108,"locationsCount":109},{"fullName":5,"class":6},"Stanford University","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Active dTMS","EXPERIMENTAL","Participants will receive 30 sessions of active-dTMS to the dACC\u002FmPFC with the H7 coil, administered 3 times per day over 10 consecutive business days. Each treatment visit will last approximately 30 minutes in total.",[13],"Device: Deep Transcranial Magnetic Stimulation (dTMS) H7 coil - Active",{"label":15,"type":16,"description":17,"interventionNames":18},"Sham dTMS","SHAM_COMPARATOR","Participants will receive 30 sham dTMS sessions, administered 3 times per day over 10 consecutive business days. Each treatment visit will last approximately 30 minutes in total.",[19],"Device: Deep Transcranial Magnetic Stimulation (dTMS) H7 coil - Sham",[21,27],{"type":22,"name":23,"description":24,"armGroupLabels":25,"otherNames":26},"DEVICE","Deep Transcranial Magnetic Stimulation (dTMS) H7 coil - Active","The study will utilize the H7 coil to administer active Deep Transcranial Magnetic Stimulation (dTMS) to the dorsal anterior cingulate cortex (dACC), a core salience network node.",[9],null,{"type":22,"name":28,"description":29,"armGroupLabels":30,"otherNames":26},"Deep Transcranial Magnetic Stimulation (dTMS) H7 coil - Sham","The study will utilize an identical protocol using the H7 coil to administer a sham condition.",[15],[32,35],{"name":33,"affiliation":5,"role":34},"Claudia B Padula, PhD","PRINCIPAL_INVESTIGATOR",{"name":36,"affiliation":5,"role":34},"Michelle R Madore, PhD",[38,44],{"name":39,"role":40,"phone":41,"phoneExt":42,"email":43},"Samantha J Ward, BS","CONTACT","650-493-5000","64975","samward@stanford.edu",{"name":45,"role":40,"phone":46,"phoneExt":26,"email":47},"Eileen G Fischer, BS","210-993-2065","grace.fischer@stanford.edu",[49],{"facility":50,"status":51,"city":52,"state":53,"zip":54,"country":55,"countryCode":56,"cosmosGeoPoint":57,"geoPoint":62,"contacts":63},"VA Palo Alto Health Care System","RECRUITING","Palo Alto","California","94304","United States","US",{"type":58,"coordinates":59},"Point",[60,61],-122.14302,37.44188,{"lat":61,"lon":60},[64,65,66],{"name":45,"role":40,"phone":46,"phoneExt":26,"email":47},{"name":33,"role":34,"phone":26,"phoneExt":26,"email":26},{"name":36,"role":34,"phone":26,"phoneExt":26,"email":26},{"type":34,"investigatorFullName":68,"investigatorTitle":69,"investigatorAffiliation":5,"oldNameTitle":26,"oldOrganization":26},"Claudia Padula","Assistant Professor",[71],{"name":72,"class":73},"National Institute on Alcohol Abuse and Alcoholism (NIAAA)","NIH","100589054","assessing-the-impact-of-dtms-on-neural-targets-associated-with-alcohol-use-disorder-100589054",false,"NCT06949423","Assessing the Impact of dTMS on Neural Targets Associated With Alcohol Use Disorder","Accessing the Impact of Deep TMS Neuromodulation on Neural Circuits Associated With Alcohol Use Disorder","NEST-A","Inclusion Criteria:\n\n* Age 18-75.\n* Current DSM-5 diagnosis of moderate to severe AUD (\\≥4 diagnostic symptoms).\n* Ability to obtain a Motor Threshold (MT) will be determined during the screening process.\n* Has an adequately stable condition and environment to enable attendance at scheduled clinic visits.\n* Able to read, understand and voluntarily sign the Informed Consent Form prior to participating in any study-specific procedures or assessments.\n* If on a medication regimen for comorbid symptoms, that regimen will be stable for the duration of the study and patient will be willing to remain on this regimen during the treatment phase.\n* Fluency in English.\n\nExclusion Criteria:\n\n* Transcranial magnetic stimulation (TMS) and magnetic resonance imaging (MRI) contraindications: such as a cardiac pacemaker, cochlear implant, or an implanted device (deep brain stimulation, metal in the head, metal in the body, claustrophobia, pregnant or breastfeeding or other ferromagnetic device\u002Fobjected in the head and body within 30 cm of the treatment coil.\n* General medical condition, disease or neurological disorder that interferes with the assessments or participation.\n* Unable to safely withdraw, at least two weeks prior to treatment, from medications that increase seizure risk.\n* Current substance abuse (except caffeine or nicotine) as determined by positive toxicology screen.\n* Have a mass lesion, cerebral infarct, or other active CNS disease, including an alcohol-related seizure or a seizure disorder.\n* A recent suicide attempt (defined as within the last 30 days) or presence of current suicidal plan or intent. Patients at risk for suicide will be required to establish a written safety plan involving their primary therapist before entering the study.\n* Severe impediment to vision, hearing and\u002For hand movement, likely to interfere with the ability to follow study protocols.\n* Greater than mild traumatic brain injury (defined as greater than 10 minutes loss of consciousness).\n* Taking benzodiazepine or neuroleptic medications, or any medication known to alter seizure threshold\n* Acute or unstable chronic illness.\n* Current or lifetime history of bipolar disorder or psychosis","ALL","18 Years","75 Years",{"count":86,"type":87},100,"ESTIMATED","INTERVENTIONAL",[90],"NA","The purpose of this study is to evaluate the efficacy of deep transcranial magnetic stimulation as a treatment for Veterans with Alcohol Use Disorder (AUD) to decrease the exceedingly high rate of relapse associated with this condition.",[93,94],"Alcohol Use Disorder (AUD)","Transcranial Magnetic Stimilation",[96,97,98,99],"Veterans","Deep Transcranial Magnetic Stimulation (dTMS)","Neuroimaging","Relapse","2026-05-12",{"date":102,"type":103},"2026-05-15","ACTUAL",{"date":105,"type":103},"2025-12-17",{"date":107,"type":87},"2030-06-30",{"name":5,"class":6},1]